129 related articles for article (PubMed ID: 8273766)
1. Effects of acute buprenorphine on responses to intranasal cocaine: a pilot study.
Rosen MI; Pearsall HR; McDougle CJ; Price LH; Woods SW; Kosten TR
Am J Drug Alcohol Abuse; 1993; 19(4):451-64. PubMed ID: 8273766
[TBL] [Abstract][Full Text] [Related]
2. Acute interactions of buprenorphine with intravenous cocaine and morphine: an investigational new drug phase I safety evaluation.
Teoh SK; Mendelson JH; Mello NK; Kuehnle J; Sintavanarong P; Rhoades EM
J Clin Psychopharmacol; 1993 Apr; 13(2):87-99. PubMed ID: 8463453
[TBL] [Abstract][Full Text] [Related]
3. Buprenorphine effects on morphine- and cocaine-induced subjective responses by drug-dependent men.
Teoh SK; Mello NK; Mendelson JH; Kuehnle J; Gastfriend DR; Rhoades E; Sholar W
J Clin Psychopharmacol; 1994 Feb; 14(1):15-27. PubMed ID: 8151000
[TBL] [Abstract][Full Text] [Related]
4. Buprenorphine in opiate withdrawal: a comparison with clonidine.
Nigam AK; Ray R; Tripathi BM
J Subst Abuse Treat; 1993; 10(4):391-4. PubMed ID: 8257551
[TBL] [Abstract][Full Text] [Related]
5. Amantadine does not reduce cocaine use or craving in cocaine-dependent methadone maintenance patients.
Handelsman L; Limpitlaw L; Williams D; Schmeidler J; Paris P; Stimmel B
Drug Alcohol Depend; 1995 Oct; 39(3):173-80. PubMed ID: 8556965
[TBL] [Abstract][Full Text] [Related]
6. Controlled opioid withdrawal evaluation during 72 h dose omission in buprenorphine-maintained patients.
Eissenberg T; Johnson RE; Bigelow GE; Walsh SL; Liebson IA; Strain EC; Stitzer ML
Drug Alcohol Depend; 1997 Apr; 45(1-2):81-91. PubMed ID: 9179510
[TBL] [Abstract][Full Text] [Related]
7. Assessment of differential doses of buprenorphine for long term pharmacotherapy among opiate dependent subjects.
De S; Jain R; Ray R; Dhawan A; Varghese ST
Indian J Physiol Pharmacol; 2008; 52(1):53-63. PubMed ID: 18831352
[TBL] [Abstract][Full Text] [Related]
8. P300 assessment of opiate and cocaine users: effects of detoxification and buprenorphine treatment.
Kouri EM; Lukas SE; Mendelson JH
Biol Psychiatry; 1996 Oct; 40(7):617-28. PubMed ID: 8886295
[TBL] [Abstract][Full Text] [Related]
9. Buprenorphine attenuates the effects of cocaine on adrenocorticotropin (ACTH) secretion and mood states in man.
Mendelson JH; Teoh SK; Mello NK; Ellingboe J
Neuropsychopharmacology; 1992 Sep; 7(2):157-62. PubMed ID: 1329800
[TBL] [Abstract][Full Text] [Related]
10. Treatment of heroin addicts using buprenorphine.
Kosten TR; Morgan C; Kleber HD
Am J Drug Alcohol Abuse; 1991 Jun; 17(2):119-28. PubMed ID: 1862786
[TBL] [Abstract][Full Text] [Related]
11. Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index.
Strain EC; Stitzer ML; Liebson IA; Bigelow GE
J Clin Psychopharmacol; 1996 Feb; 16(1):58-67. PubMed ID: 8834420
[TBL] [Abstract][Full Text] [Related]
12. Treatment of cocaine abuse with buprenorphine.
Kosten TR; Kleber HD; Morgan C
Biol Psychiatry; 1989 Oct; 26(6):637-9. PubMed ID: 2790101
[No Abstract] [Full Text] [Related]
13. Abuse liability of buprenorphine--a study among experienced drug users.
Bedi NS; Ray R; Jain R; Dhar NK
Indian J Physiol Pharmacol; 1998 Jan; 42(1):95-100. PubMed ID: 9513799
[TBL] [Abstract][Full Text] [Related]
14. A randomized double-blind study of neuroelectric therapy in opiate and cocaine detoxification.
Gariti P; Auriacombe M; Incmikoski R; McLellan AT; Patterson L; Dhopesh V; Mezochow J; Patterson M; O'Brien C
J Subst Abuse; 1992; 4(3):299-308. PubMed ID: 1458046
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine misuse among heroin and amphetamine users in Malmo, Sweden: purpose of misuse and route of administration.
Hakansson A; Medvedeo A; Andersson M; Berglund M
Eur Addict Res; 2007; 13(4):207-15. PubMed ID: 17851242
[TBL] [Abstract][Full Text] [Related]
16. Buprenorphine suppresses heroin use by heroin addicts.
Mello NK; Mendelson JH
Science; 1980 Feb; 207(4431):657-9. PubMed ID: 7352279
[TBL] [Abstract][Full Text] [Related]
17. Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects.
Chawla JM; Pal H; Lal R; Jain R; Schooler N; Balhara YP
J Opioid Manag; 2013; 9(1):35-41. PubMed ID: 23709302
[TBL] [Abstract][Full Text] [Related]
18. Buprenorphine/naloxone reduces the reinforcing and subjective effects of heroin in heroin-dependent volunteers.
Comer SD; Walker EA; Collins ED
Psychopharmacology (Berl); 2005 Oct; 181(4):664-75. PubMed ID: 16025322
[TBL] [Abstract][Full Text] [Related]
19. Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone.
Oliveto AH; Feingold A; Schottenfeld R; Jatlow P; Kosten TR
Arch Gen Psychiatry; 1999 Sep; 56(9):812-20. PubMed ID: 12884887
[TBL] [Abstract][Full Text] [Related]
20. [Abuse of alcohol and benzodiazepine during substitution therapy in heroin addicts: a review of the literature].
Laqueille X; Launay C; Dervaux A; Kanit M
Encephale; 2009 Jun; 35(3):220-5. PubMed ID: 19540407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
